Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
RNA Pol II Loss and Apoptotic Signaling
2026-09-04
Harper et al. show that RNA polymerase II inhibition can trigger apoptosis through active sensing of the hypophosphorylated RNA Pol IIA pool rather than through passive loss of transcription and mRNA. The study defines a Pol II degradation-dependent apoptotic response and provides a framework for interpreting the cytotoxicity of transcription-targeting and other anticancer compounds.
-
Curcumin, PBDE-47, and NET Formation
2026-09-04
The reference study identifies PBDE-47 as an inducer of neutrophil extracellular traps and links this response to Nrf2-associated reactive oxygen species. Its findings suggest that curcumin can suppress toxicant-associated NET formation, while the imaging and biochemical workflow provides a useful framework for studying pollutant–immune interactions.
-
Angiotensin II Workflows for Fibrosis Research
2026-09-03
Build reproducible Angiotensin II experiments that connect GPCR signaling with vascular remodeling, oxidative stress, and renal fibrotic pathways. This practical guide combines cell-based stimulation, translational animal-model considerations, and troubleshooting informed by a RIG-I–c-Myc fibrosis study.
-
CAPE in the Fyn–Stat3–NF-κB Axis
2026-09-03
Caffeic Acid Phenethyl Ester (CAPE) offers translational researchers a selective chemical probe for testing the NF-κB arm of Fyn-driven neuroinflammation. By connecting the 2024 zebrafish study of Fyn, Stat3, and NF-κB with practical CAPE workflows, this article frames the compound as a mechanistic decision tool rather than a stand-alone therapeutic claim.
-
Linoleic Acid: Practical Assay Workflow
2026-09-02
Linoleic Acid (SKU C3108; C18:2(9Z,12Z)) provides a defined omega-6 fatty acid input for membrane, oxidative stress, erythrocyte, epithelial migration, and nutritional deficiency workflows. It is water-insoluble and is not appropriate for aqueous-only protocols or experiments dependent on long-term stock-solution stability.
-
Fasudil (HA-1077) HCl in Cell Assays
2026-09-02
A scenario-based guide to using Fasudil (HA-1077) HCl, SKU A5734, for interpretable cell viability, proliferation, migration, and apoptosis assays. It covers mechanism, solvent compatibility, dose-finding, data interpretation, and practical vendor-selection criteria.
-
Bsa I (RNase-free): Practical DNA Cleavage Guide
2026-09-01
Bsa I (RNase-free) provides sequence-directed cleavage for DNA manipulation, gene cloning, and other recombinant DNA workflows where RNA preservation is important. It is intended for molecular biology research only and should not be used for diagnostic, clinical, or medical applications.
-
Carbenoxolone disodium: Protocol & QC
2026-09-01
Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. Use it in defined cell, enzyme, or tissue workflows with matched vehicles and orthogonal controls; do not treat it as a selective in vivo efficacy probe or a stand-alone basis for clinical interpretation.
-
EdU Imaging Kits for HCC Proliferation
2026-08-31
EdU Imaging Kits (HF488) connect S-phase DNA synthesis measurement with microscopy and flow cytometry, making them useful for validating hepatocellular carcinoma biomarkers and drug-response hypotheses. Their antibody-free click-chemistry workflow preserves morphology and antigen-binding sites while providing quantitative proliferation endpoints.
-
Sulfisomidine Workflows for Enzyme and Microbial Research
2026-08-31
Sulfisomidine, also known as sulfamethin, connects PABA-dependent microbial studies with hPON1 inhibition, oxidative stress regulation research, and environmental transformation workflows. This practical guide covers assay setup, concentration planning, time-course design, and troubleshooting for reproducible in vitro experiments.
-
Lyso-Tracker Red for Lysosome Assays
2026-08-30
Lyso-Tracker Red enables live-cell visualization of acidic lysosomes during nanoparticle uptake, maturation, and intracellular trafficking. This practical workflow connects lysosomal imaging with the CLam/OVA vaccine-adjuvant study while clarifying how to distinguish acidification, compartment morphology, and lysosomal escape.
-
HyperPFU™ high-fidelity DNA polymerase guide
2026-08-29
HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It produces blunt-ended PCR products for cloning and sequencing, but is not the appropriate choice when a workflow requires 3′-A overhangs or preformed sticky ends.
-
Tin Mesoporphyrin IX: A Causal HO Probe
2026-08-28
Tin Mesoporphyrin IX (chloride) enables researchers to move beyond HO-1 expression measurements and test whether heme oxygenase activity causally shapes ROS, heme catabolism, and viral phenotypes. This article develops an assay-to-mechanism framework grounded in recent HBV research and practical experimental controls.
-
Gap26: Connexin 43 Mimetic Peptide Workflows
2026-08-28
Gap26 gives researchers a practical way to interrupt connexin 43-dependent communication while tracking calcium waves, ATP release, and mitochondrial transfer. This guide translates validated product parameters and a 2025 liver-graft study into cell, tissue, and in vivo workflows with controls that help distinguish channel blockade from nonspecific toxicity.
-
Nullscript: A Histone Deacetylase Inhibitor
2026-08-27
Nullscript is a histone deacetylase inhibitor and close analog of scriptaid with an unusual transcriptional-facilitation profile. Product information reports approximately 46.8% in vivo myocardial infarct size reduction in a murine cardiac ischemia/reperfusion model, but no clinical evidence is available.